Avantor, Inc. (NYSE:AVTR) Shares Acquired by Thematics Asset Management

Thematics Asset Management increased its stake in shares of Avantor, Inc. (NYSE:AVTRFree Report) by 9.8% in the 3rd quarter, HoldingsChannel reports. The firm owned 950,000 shares of the company’s stock after purchasing an additional 85,000 shares during the period. Thematics Asset Management’s holdings in Avantor were worth $24,576,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Swedbank AB purchased a new stake in Avantor in the first quarter valued at $2,707,000. Sound Shore Management Inc. CT acquired a new stake in shares of Avantor in the 2nd quarter valued at about $76,412,000. Seven Eight Capital LP purchased a new position in Avantor during the 2nd quarter worth approximately $642,000. New York State Teachers Retirement System acquired a new position in Avantor during the third quarter worth approximately $8,473,000. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of Avantor by 35.1% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,157,855 shares of the company’s stock valued at $24,547,000 after acquiring an additional 300,579 shares during the period. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Morgan Stanley upped their price target on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Wells Fargo & Company dropped their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. UBS Group lowered their price objective on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, October 8th. Stifel Nicolaus raised their price objective on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $27.57.

Check Out Our Latest Stock Report on AVTR

Avantor Trading Down 1.9 %

Shares of NYSE:AVTR traded down $0.40 during trading on Tuesday, reaching $20.70. The stock had a trading volume of 714,127 shares, compared to its average volume of 6,486,139. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The business has a fifty day moving average price of $23.77 and a 200-day moving average price of $23.82. The stock has a market cap of $14.09 billion, a P/E ratio of 45.89, a PEG ratio of 2.52 and a beta of 1.35. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

Insiders Place Their Bets

In other news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. This represents a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.30% of the company’s stock.

Avantor Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Further Reading

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.